Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

Market Cap	4.56B
Revenue (ttm)	818.31M
Net Income (ttm)	42.91M
Shares Out	499.86M
EPS (ttm)	0.08
PE Ratio	112.66
Forward PE	31.48
Dividend	0.05 (0.54%)
Ex-Dividend Date	Jul 25, 2025

Volume	23,337,068
Average Volume	23,244,410
Open	9.27
Previous Close	9.19
Day's Range	9.09 - 9.32
52-Week Range	6.79 - 10.40
Beta	1.96
RSI	59.16
Earnings Date	Jul 25, 2025

About SHE:002728

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patent medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China. The company offers cough and phlegm, kidney, anti- infection, cardiovascular and cerebrovascular, and digestive system drugs, as well as pediatrics, dermatology, tuberculosis, respiratory, rheumatology, nephrology, and endocrinology medicines. Its chemical raw materials and products include aluminum carbonate, phenytoin, ferrous su...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 1,341
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002728

Financial Performance

In 2024, SHE:002728's revenue was 687.79 million, a decrease of -35.55% compared to the previous year's 1.07 billion. Earnings were 20.50 million, a decrease of -91.90%.